Balloon-assisted subintimal entry (BASE) in chronic total occlusion percutaneous coronary interventions.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
11 2023
Historique:
revised: 21 08 2023
received: 23 06 2023
accepted: 27 08 2023
medline: 15 11 2023
pubmed: 7 9 2023
entrez: 7 9 2023
Statut: ppublish

Résumé

There is limited data on the use of the balloon-assisted subintimal entry (BASE) technique in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We analyzed the baseline clinical and angiographic characteristics and outcomes of 155 CTO PCIs that utilized the BASE technique at 31 US and non-US centers between 2016 and 2023. The BASE technique was used in 155 (7.9%) of 1968 antegrade dissection and re-entry (ADR) cases performed during the study period. The mean age was 66 ± 10 years, 88.9% of the patients were men, and the prevalence of diabetes (44.6%), hypertension (90.5%), and dyslipidemia (88.7%) was high. Compared with 1813 ADR cases that did not use BASE, the target vessel of the BASE cases was more commonly the RCA and less commonly the LAD. Lesions requiring BASE had longer occlusion length (42 ± 23 vs. 37 ± 23 mm, p = 0.011), higher Japanese CTO (J-CTO) (3.4 ± 1.0 vs. 3.0 ± 1.1, p < 0.001) and PROGRESS-CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention chronic total occlusion) (1.8 ± 1.0 vs. 1.5 ± 1.0, p = 0.008) scores, and were more likely to have proximal cap ambiguity, side branch at the proximal cap, blunt/no stump, moderate to severe calcification, and proximal tortuosity. Technical (71.6% vs. 75.5%, p = 0.334) and procedural success (71.6% vs. 72.8%, p = 0.821), as well as major adverse cardiac events (MACE) (1.3% vs. 4.1%, p = 0.124), were similar in ADR cases that used BASE and those that did not. The BASE technique is used in CTOs with longer occlusion length, higher J-CTO score, and more complex angiographic characteristics, and is associated with moderate success but also low MACE.

Sections du résumé

BACKGROUND
There is limited data on the use of the balloon-assisted subintimal entry (BASE) technique in chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
METHODS
We analyzed the baseline clinical and angiographic characteristics and outcomes of 155 CTO PCIs that utilized the BASE technique at 31 US and non-US centers between 2016 and 2023.
RESULTS
The BASE technique was used in 155 (7.9%) of 1968 antegrade dissection and re-entry (ADR) cases performed during the study period. The mean age was 66 ± 10 years, 88.9% of the patients were men, and the prevalence of diabetes (44.6%), hypertension (90.5%), and dyslipidemia (88.7%) was high. Compared with 1813 ADR cases that did not use BASE, the target vessel of the BASE cases was more commonly the RCA and less commonly the LAD. Lesions requiring BASE had longer occlusion length (42 ± 23 vs. 37 ± 23 mm, p = 0.011), higher Japanese CTO (J-CTO) (3.4 ± 1.0 vs. 3.0 ± 1.1, p < 0.001) and PROGRESS-CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention chronic total occlusion) (1.8 ± 1.0 vs. 1.5 ± 1.0, p = 0.008) scores, and were more likely to have proximal cap ambiguity, side branch at the proximal cap, blunt/no stump, moderate to severe calcification, and proximal tortuosity. Technical (71.6% vs. 75.5%, p = 0.334) and procedural success (71.6% vs. 72.8%, p = 0.821), as well as major adverse cardiac events (MACE) (1.3% vs. 4.1%, p = 0.124), were similar in ADR cases that used BASE and those that did not.
CONCLUSIONS
The BASE technique is used in CTOs with longer occlusion length, higher J-CTO score, and more complex angiographic characteristics, and is associated with moderate success but also low MACE.

Identifiants

pubmed: 37676010
doi: 10.1002/ccd.30830
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

834-843

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Brilakis ES. Manual of Coronary Chronic Total Occlusion Interventions: A Step-by-Step Approach. 3rd ed. Elsevier; 2023.
Vo MN, Karmpaliotis D, Brilakis ES. “Move the cap” technique for ambiguous or impenetrable proximal cap of coronary total occlusion: move the cap technique. Catheter Cardiovasc Interv. 2016;87(4):742-748.
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377-381.
Ybarra LF, Rinfret S, Brilakis ES, et al. Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC Consensus Recommendations. Circulation. 2021;143(5):479-500.
Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020-2035.
Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes. JACC Cardiovasc Interv. 2011;4(2):213-221.
Christopoulos G, Kandzari DE, Yeh RW, et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions. JACC Cardiovasc Interv. 2016;9(1):1-9.
Simsek B, Kostantinis S, Karacsonyi J, et al. Predicting periprocedural complications in chronic total occlusion percutaneous coronary intervention. JACC Cardiovasc Interv. 2022;15(14):1413-1422.
Kostantinis S, Simsek B, Karacsonyi J, et al. Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation score. EuroIntervention. 2023;18(12):1022-1030.
Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247-254.
van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1-67.
Granger E, Sergeant JC, Lunt M. Avoiding pitfalls when combining multiple imputation and propensity scores. Stat Med. 2019;38(26):5120-5132.
Kostantinis S, Simsek B, Karacsonyi J, et al. Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-CTO Registry. Catheter Cardiovasc Interv. 2023;101(4):737-746.
Riley RF, Walsh SJ, Kirtane AJ, et al. Algorithmic solutions to common problems encountered during chronic total occlusion angioplasty: the algorithms within the algorithm. Catheter Cardiovasc Interv. 2019;93(2):286-297.
Wu EB, Brilakis ES, Mashayekhi K, et al. Global chronic total occlusion crossing algorithm. J Am Coll Cardiol. 2021;78(8):840-853.
Roy J, Hill J, Spratt JC. The “side-BASE technique”: combined side branch anchor balloon and balloon assisted sub-intimal entry to resolve ambiguous proximal cap chronic total occlusions. Catheter Cardiovasc Interv. 2018;92(1):E15-E19.
Creaney C, Walsh SJ. Antegrade chronic total occlusion strategies: a technical focus for 2020. Interv Cardiol Rev. 2020;15:e08.
Maeremans J, Dens J, Spratt JC, et al. Antegrade dissection and reentry as part of the hybrid chronic total occlusion revascularization strategy. Circ Cardiovasc Interv. 2017;10(6):e004791.
Danek BA, Karatasakis A, Karmpaliotis D, et al. Use of antegrade dissection re-entry in coronary chronic total occlusion percutaneous coronary intervention in a contemporary multicenter registry. Int J Cardiol. 2016;214:428-437.
Kostantinis S, Simsek B, Karacsonyi J, et al. Incidence, mechanisms, treatment, and outcomes of coronary artery perforation during chronic total occlusion percutaneous coronary intervention. Am J Cardiol. 2022;182:17-24.
Michael TT, Papayannis AC, Banerjee S, Brilakis ES. Subintimal dissection/reentry strategies in coronary chronic total occlusion interventions. Circ Cardiovasc Interv. 2012;5(5):729-738.
Azzalini L, Carlino M, Brilakis ES, et al. Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: the concept of “vessel architecture”. Catheter Cardiovasc Interv. 2018;91(4):725-734.

Auteurs

Michaella Alexandrou (M)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Athanasios Rempakos (A)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Ahmed Al Ogaili (A)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

James W Choi (JW)

Texas Health Presbyterian Hospital, Dallas, Texas, USA.

Paul Poommipanit (P)

University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.

Khaldoon Alaswad (K)

Henry Ford Cardiovascular Division, Detroit, Michigan, USA.

Mir B Basir (MB)

Henry Ford Cardiovascular Division, Detroit, Michigan, USA.

Rhian Davies (R)

WellSpan York Hospital, York, Pennsylvania, USA.

Stewart Benton (S)

WellSpan York Hospital, York, Pennsylvania, USA.

Farouc A Jaffer (FA)

Massachusetts General Hospital, Boston, Massachusetts, USA.

Raj H Chandwaney (RH)

Oklahoma Heart Institute, Tulsa, Oklahoma, USA.

Lorenzo Azzalini (L)

Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.

Kathleen E Kearney (KE)

Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.

Ahmed M ElGuindy (AM)

Aswan Heart Center, Magdi Yacoub Foundation, Cairo, Egypt.

Nidal Abi Rafeh (N)

North Oaks Health System, Hammond, Louisiana, USA.

Omer Goktekin (O)

Memorial Bahcelievler Hospital, Istanbul, Turkey.

Sevket Gorgulu (S)

Biruni University Medical School, Istanbul, Turkey.

Jaikirshan J Khatri (JJ)

Cleveland Clinic, Cleveland, Ohio, USA.

Nazif Aygul (N)

Selcuk University, Konya, Turkey.

Minh N Vo (MN)

Royal Columbian Hospital, Vancouver, British Columbia, Canada.

Altug Cincin (A)

Marmara University School of Medicine Pendik, Training and Research Hospital, Kaynarca, Turkey.

Bavana V Rangan (BV)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Olga C Mastrodemos (OC)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Salman S Allana (SS)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Yader Sandoval (Y)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

M Nicholas Burke (MN)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Emmanouil S Brilakis (ES)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH